Shanghai, China

Xing Xia

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Innovations of Xing Xia in the Field of Glycopeptide Compounds

Introduction

Xing Xia is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in developing glycopeptide compounds that combat drug-resistant bacteria. His work is crucial in addressing the growing concern of antibiotic resistance in modern medicine.

Latest Patents

Xing Xia holds a patent for glycopeptide compounds that exhibit activity against drug-resistant bacteria. The patent, titled "Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof," outlines a novel preparation method and application for these compounds. The glycopeptide compounds conform to a general formula and have shown higher inhibition activity against drug-resistant strains, particularly MRSA and VRE, compared to existing treatments like oritavancin. Furthermore, these compounds demonstrate a safety profile that is superior to that of oritavancin, making them promising candidates for treating various bacterial infections, including skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.

Career Highlights

Xing Xia has worked with prominent companies in the biopharmaceutical sector, including Shanghai Laiyi Center for Biopharmaceutical R&D Co., Ltd. and Zhejiang Medicine Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for combating bacterial infections.

Collaborations

Xing Xia has collaborated with notable colleagues in his field, including Chang Shao and Mei Ge. Their combined efforts have further advanced the research and development of effective treatments against drug-resistant bacteria.

Conclusion

Xing Xia's innovative work in glycopeptide compounds represents a significant advancement in the fight against antibiotic resistance. His contributions are vital for developing new treatments that can effectively address serious bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…